PATENT CLAIM ANALYSIS

Application Number: 16001012
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["548", "302100"]

Abstract:
In certain embodiments, the disclosure relates to heterocyclic flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diseases or conditions related to BDNF and TrkB activity, such as depression, stroke, Rett syndrome, Parkinson's disease, and Alzheimer's disease by administering effective amounts of pharmaceutical compositions comprising compounds disclosed herein.

Claim (Index 10):
The method of  claim 7 , wherein the compound of formula I is administered in combination with galantamine.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 94.0
- Lexical Diversity: 1.65306
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15416964', '14410756', '14639343', '13643769', '15593654']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8323567568821658
- 35 USC 102 Novelty (BERT): 0.5952994603747337
- Combined Prediction Score: 0.8086510272314227
- Mean Citation Score: 607.7851099999998
- Max Citation Score: 721.93427
- Similarity Product: 410.7557320534981

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test